Catamaran Corporation (NASDAQ:CTRX) is a provider of pharmacy benefit management services and healthcare IT solutions to the healthcare benefit management industry. UnitedHealth Group completed its purchase of Catamaran this past summer for $61.50 per share in cash. While we were disappointed to lose a potential “compounder” early on in our investment, we believe we received full and fair value for our shares. We continue to have exposure to the attractive pharmacy benefit management (PBM) segment through a position in Express Scripts.
From Wallace Weitz (Trades, Portfolio)'s fourth quarter 2015 Value Fund commentary.
